Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
about
Cardiovascular disease in systemic sclerosis--an emerging association?Cardiovascular disease in systemic sclerosis.Dyslipidaemia in rheumatological autoimmune diseasesThe risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.Distribution of macrovascular disease in sclerodermaMacrovascular disease and systemic sclerosis.European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsIsolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis - a lethal combination.Atherosclerosis in Systemic Sclerosis: a Modern Controversy.Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.Scleroderma therapy: clinical overview of current trends and future perspective.A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis.Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.Catheter angiography and angioplasty in patients with scleroderma.Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.A longitudinal study of ankle brachial pressure indices in a cohort of patients with systemic sclerosis.Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series.Subclinical atherosclerosis in scleroderma patients.Reply: To PMID 22899452.Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study.Evidence of cerebral hypoperfusion in scleroderma patients.Early identification of vascular damage in patients with systemic sclerosis.Evaluation of arterial stiffness and hemodynamics by oscillometric method in patients with systemic sclerosis."No-reflow" phenomenon during percutaneous carotid angioplasty in a scleroderma patient.Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
P2860
Q21195262-F4C82DC6-C107-4C63-B37D-D8E658E6C2F8Q34947193-FCAD9BD2-1280-4B87-9A71-11CEB1760B8EQ35029916-26A96747-3E12-4FC6-8076-B974B4F9099FQ35283742-B8348384-14B4-4AAF-8126-197B887ABB63Q35548113-F3E538ED-1753-4B0A-8F50-1A0842C53EAAQ35548842-2C36B859-5E1E-4E69-9D70-35D54EB49732Q35550528-A22BB29B-3F51-42E0-965F-1885A8BB5119Q36757042-272874A0-5CEB-4C5D-B02F-7DF2B10E935FQ36856521-324A1533-7C8B-4B4F-A65D-466FEF90F5BEQ37668990-2B8EB2EC-DBAE-45AA-8B72-857CECC78A39Q37690928-853A15A5-1CFB-44F5-B37A-0B38D4AA594BQ38046467-5DBA7567-FF96-4BBC-91FD-ADC2760DFA1AQ38425913-E3C442C1-9B53-4859-B37F-5CBCE95AE2A4Q38446736-542AFB24-7849-416E-9286-F91C1381F7DDQ39589913-51E42B0A-EB0C-479B-80EF-5350D1A3490DQ39977068-FD7DC14D-CCFC-4491-85F0-126D5186AA0DQ40198680-9ADAAF8B-8331-4221-80C5-0575FCE76A1BQ40371203-9DFD4D16-53E4-42A1-8C81-68C971CDB6BEQ43061735-99DFFDA1-144A-444A-86D9-A6C27D5E6208Q44715187-55C91E88-CADE-4222-86FF-A67BD80AF326Q46506708-B4E969BC-675B-4D98-B1E3-860C62EC4E5CQ49120029-CA3CE2D8-5B3E-4524-9115-3B649128794CQ50683587-2FF6EA35-3091-4B30-9457-695B6B1633DBQ51188002-6EEA7BA4-B9B9-4184-97B7-86E459E8BE5EQ51611405-1A04573F-92E8-4DFA-A686-122E2F38AEE1Q51684920-1B365607-A185-4D5B-ADA6-604F3BA164D5
P2860
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@ast
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@en
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.
@nl
type
label
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@ast
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@en
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.
@nl
prefLabel
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@ast
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@en
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.
@nl
P2860
P356
P1476
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis
@en
P2093
T A Collidge
P2860
P304
P356
10.1136/ARD.54.10.853
P407
P577
1995-10-01T00:00:00Z